<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01747304</url>
  </required_header>
  <id_info>
    <org_study_id>IVA 12-0352-AE</org_study_id>
    <nct_id>NCT01747304</nct_id>
  </id_info>
  <brief_title>Evaluation of IVA (SE Femur Scans) to Identify Incomplete AFFs</brief_title>
  <official_title>Evaluation of Dual Energy X-ray Absorptiometry Scanners in the Identification of Atypical Femur Fractures - A Validation Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      DXA scanners are routinely used to assess bone mineral density (BMD) and fracture risk in
      osteoporosis patients. They provide detailed bone imaging in a low radiation setting. Hologic
      manufactures scanners that are able to perform high definition instant vertebral fracture
      assessment (HD-IVA) used to screen at-risk patients for asymptomatic spine fractures
      instantly and reliably at the same time they are having their yearly BMD. We wish to
      investigate whether this same proven technology (HD-IVA scan mode) used on femurs (the scan
      mode is now called SE Femur scans) can be used to screen for atypical fractures of the femur
      in patients at risk for these debilitating fractures. In this proof of concept study, we
      propose to examine whether DXA scanners can provide a sensitive low radiation screening
      method to identify incomplete AFFs in patients with known incomplete AFFs and in patients at
      risk.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HD-IVA visualization of incomplete femur fractures</measure>
    <time_frame>1 day (one time point )</time_frame>
    <description>Hologic DXA scanner using the high-definition IVA (HD-IVA) mode on femur bones will be able to visualize incomplete femur fractures at least 90% of the time in patients with known incomplete AFF.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Atypical Femur Fracture</condition>
  <arm_group>
    <arm_group_label>Screening population</arm_group_label>
    <description>Healthy post-menopausal women attending bone mineral density screening clinic with leg/hip/groin pain/discomfort/weakness an has been on anti-resorptive therapy for at least 5 years.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comparator Group</arm_group_label>
    <description>Control group from Toronto CaMOS cohort willing to participate.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>AFF group</arm_group_label>
    <description>participants in the AFF Cohort study at UHN</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DXA Se femur scans (previously called IVA femur)</intervention_name>
    <description>Single Energy Beam (previously called inter-vertebral assessment) by Dual energy x-ray absorptiometry of affected femur</description>
    <arm_group_label>Screening population</arm_group_label>
    <arm_group_label>Comparator Group</arm_group_label>
    <arm_group_label>AFF group</arm_group_label>
    <other_name>SF Femur scans</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Osteoporosis/Bone Mineral Density Lab out-patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Known AFF group

          1. A subject must have experienced an incomplete atypical low trauma fracture of the
             femoral shaft;

          2. Is a patient at the UHN osteoporosis clinic.

        Comparison Group

          1. Must be scheduled for a bone mineral density scan at UHN

          2. Have been on any bisphosphonate for 5 years or longer, and;

          3. Have unexplained symptoms of leg, hip, thigh, or knee pain.

        Exclusion Criteria:

          -  There are no exclusions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela M Cheung, MD, PhD, CCD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Judite Scher, MSc CCRI</last_name>
    <phone>416-340-4841</phone>
    <email>jscher@uhnresearch.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scher</last_name>
      <email>jscher@uhnresearch.ca</email>
    </contact>
    <investigator>
      <last_name>Angela M Cheung, MD, PhD, CCD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2012</study_first_submitted>
  <study_first_submitted_qc>December 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2012</study_first_posted>
  <last_update_submitted>May 11, 2018</last_update_submitted>
  <last_update_submitted_qc>May 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Atypical Femur Fracture</keyword>
  <keyword>DXA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Femoral Fractures</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

